Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Dec;104(4):793–796. doi: 10.1111/j.1476-5381.1991.tb12508.x

Variations in potassium concentration modify the inhibitory effect of lorcainide on myocardial Na(+)-K(+)-ATPase activity.

A A Almotrefi 1, N Dzimiri 1
PMCID: PMC1908833  PMID: 1667285

Abstract

1. The inhibitory action of lorcainide on the myocardial Na(+)-K(+)-ATPase (EC 3.6.1.3) activity was studied in guinea-pig heart preparations at medium K+ concentrations of 2.5, 5.0 and 10 mM. 2. Lorcainide exhibited characteristically similar concentration-dependent inhibitory effects at all three K+ concentrations tested. However, the inhibitory potencies were significantly increased at decreased K+ concentrations. 3. The IC50 values were 10.4 +/- 3.2 microM at 2.5 mM, 28.3 +/- 7.9 microM at 5.0 mM and 40.7 +/- 9.2 microM at 10.0 mM K+ respectively. Thus, reduction in the K+ concentration from the 'standard' 5.0 to 2.5 mM enhanced the inhibitory potency of lorcainide, the effective concentrations being shifted towards much lower ranges, while increasing it to 10 mM on the other hand produced opposite but less marked effects. 4. These results show that the inhibition of myocardial Na(+)-K(+)-ATPase activity by lorcainide depends on the K+ concentration of the incubation medium. These effects are probably related to the mechanism by which lorcainide interferes with the electrogenic Na+/K+ pump activity of the enzyme, and hence may contribute to some of its cardiac actions.

Full text

PDF
793

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almotrefi A. A., Dzimiri N. Effects of quinidine, lidocaine and encainide on guinea pig myocardial Na(+)-K(+)-ATPase activity. Res Commun Chem Pathol Pharmacol. 1990 Aug;69(2):253–256. [PubMed] [Google Scholar]
  2. Almotrefi A. A., Dzimiri N. Influence of lorcainide on microsomal Na+, K(+)-ATPase in guinea-pig isolated heart preparations. Br J Pharmacol. 1991 Feb;102(2):530–532. doi: 10.1111/j.1476-5381.1991.tb12205.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Almotrefi A. A., Dzimiri N. The influence of potassium concentration on the inhibitory effect of amiodarone on guinea-pig microsomal Na(+)-K(+)-ATPase activity. Pharmacol Toxicol. 1991 Aug;69(2):140–143. doi: 10.1111/j.1600-0773.1991.tb01287.x. [DOI] [PubMed] [Google Scholar]
  4. Aomine M. Suggestive evidence for inhibitory action of amiodarone on Na+, K+-pump activity in guinea pig heart. Gen Pharmacol. 1989;20(4):491–496. doi: 10.1016/0306-3623(89)90201-2. [DOI] [PubMed] [Google Scholar]
  5. Aronson R. S., Nordin C. Arrhythmogenic interaction between low potassium and ouabain in isolated guinea-pig ventricular myocytes. J Physiol. 1988 Jun;400:113–134. doi: 10.1113/jphysiol.1988.sp017114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cleland J. G., Dargie H. J. Arrhythmias, catecholamines and electrolytes. Am J Cardiol. 1988 Jul 11;62(2):55A–59A. doi: 10.1016/s0002-9149(88)80086-9. [DOI] [PubMed] [Google Scholar]
  7. Cook L. S., Straub K. D., Doherty J. E., Whittle J. L., Baker B. J. Digitalis-sensitive Na+, K+-ATPase: lack of a direct catecholamine-mediated stimulation in bovine myocardial tissue. J Cardiovasc Pharmacol. 1983 May-Jun;5(3):446–449. [PubMed] [Google Scholar]
  8. Dzimiri N., Almotrefi A. A. Amiodarone: biochemical evidence for its interaction with myocardial Na(+)-K(+)-ATPase in guinea pig microsomal preparations. Biochem Pharmacol. 1991 Feb 1;41(3):470–472. doi: 10.1016/0006-2952(91)90550-o. [DOI] [PubMed] [Google Scholar]
  9. Dzimiri N., Fricke U., Klaus W. Influence of derivation on the lipophilicity and inhibitory actions of cardiac glycosides on myocardial Na+-K+-ATPase. Br J Pharmacol. 1987 May;91(1):31–38. doi: 10.1111/j.1476-5381.1987.tb08980.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eibl H., Lands W. E. A new, sensitive determination of phosphate. Anal Biochem. 1969 Jul;30(1):51–57. doi: 10.1016/0003-2697(69)90372-8. [DOI] [PubMed] [Google Scholar]
  11. Ferrier G. R. Digitalis arrhythmias: role of oscillatory afterpotentials. Prog Cardiovasc Dis. 1977 May-Jun;19(6):459–474. doi: 10.1016/0033-0620(77)90010-x. [DOI] [PubMed] [Google Scholar]
  12. Fricke U., Klaus W. A simple preparation technique for a microsomal Maplus-K-plus-activated ATPase from cardiac tissues of different species. Prep Biochem. 1974;4(1):13–29. doi: 10.1080/00327487408068183. [DOI] [PubMed] [Google Scholar]
  13. Goldstein R. E., Penzotti S. C., Kuehl K. S., Prindle K. H., Jr, Hall C. A., Titus E. O., Epstein S. E. Correlation of antiarrhythmic effects of diphenylhydantoin with digoxin-induced changes in myocardial contractility, sodium-potassium adenosine triphosphatase activity, and potassium efflux. Circ Res. 1973 Aug;33(2):175–182. doi: 10.1161/01.res.33.2.175. [DOI] [PubMed] [Google Scholar]
  14. HOLLAND W. C., KLEIN R. L. Effects of temperature, Na and K concentration and quinidine on transmembrane flux of K42 and incidence of atrial fibrillation. Circ Res. 1958 Jul;6(4):516–521. doi: 10.1161/01.res.6.4.516. [DOI] [PubMed] [Google Scholar]
  15. Hafner D., Heinen E., Noack E. Mathematical analysis of concentration-response relationships. Method for the evaluation of the ED50 and the number of binding sites per receptor molecule using the logit transformation. Arzneimittelforschung. 1977;27(10):1871–1873. [PubMed] [Google Scholar]
  16. Kass R. S., Tsien R. W., Weingart R. Ionic basis of transient inward current induced by strophanthidin in cardiac Purkinje fibres. J Physiol. 1978 Aug;281:209–226. doi: 10.1113/jphysiol.1978.sp012417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kleiger R. E., Seta K., Vitale J. J., Lown B. Effects of chronic depletion of potassium and magnesium upon the action of acetylstrophanthidin on the heart. Am J Cardiol. 1966 Apr;17(4):520–527. doi: 10.1016/0002-9149(66)90243-8. [DOI] [PubMed] [Google Scholar]
  18. Levine J. H., Morganroth J., Kadish A. H. Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapy. Circulation. 1989 Oct;80(4):1063–1069. doi: 10.1161/01.cir.80.4.1063. [DOI] [PubMed] [Google Scholar]
  19. Morganroth J. Risk factors for the development of proarrhythmic events. Am J Cardiol. 1987 Apr 30;59(11):32E–37E. doi: 10.1016/0002-9149(87)90199-8. [DOI] [PubMed] [Google Scholar]
  20. Nordrehaug J. E., Johannessen K. A., von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation. 1985 Apr;71(4):645–649. doi: 10.1161/01.cir.71.4.645. [DOI] [PubMed] [Google Scholar]
  21. Obayashi K., Hayakawa H., Mandel W. J. Interrelationships between external potassium concentration and lidocaine: effects on canine Purkinje fiber. Am Heart J. 1975 Feb;89(2):221–226. doi: 10.1016/0002-8703(75)90050-2. [DOI] [PubMed] [Google Scholar]
  22. Podrid P. J., Lampert S., Graboys T. B., Blatt C. M., Lown B. Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors. Am J Cardiol. 1987 Apr 30;59(11):38E–44E. doi: 10.1016/0002-9149(87)90200-1. [DOI] [PubMed] [Google Scholar]
  23. Prasada Rao K. S., Rao S. B., Camus P. H., Mehendale H. M. Effect of amiodarone on Na+-, K+-ATPase and Mg2+-ATPase activities in rat brain synaptosomes. Cell Biochem Funct. 1986 Apr;4(2):143–151. doi: 10.1002/cbf.290040210. [DOI] [PubMed] [Google Scholar]
  24. Reid J., Duker G., Almgren O., Nerme V. (+)-sotalol causes significant occupation of beta-adrenoceptors at concentrations that prolong cardiac repolarization. Naunyn Schmiedebergs Arch Pharmacol. 1990 Mar;341(3):215–220. doi: 10.1007/BF00169733. [DOI] [PubMed] [Google Scholar]
  25. Smith T. W., Antman E. M., Friedman P. L., Blatt C. M., Marsh J. D. Digitalis glycosides: mechanisms and manifestations of toxicity. Part II. Prog Cardiovasc Dis. 1984 May-Jun;26(6):495–540. doi: 10.1016/0033-0620(84)90014-8. [DOI] [PubMed] [Google Scholar]
  26. Woosley R. L., Roden D. M. Pharmacologic causes of arrhythmogenic actions of antiarrhythmic drugs. Am J Cardiol. 1987 Apr 30;59(11):19E–25E. doi: 10.1016/0002-9149(87)90197-4. [DOI] [PubMed] [Google Scholar]
  27. Zipes D. P. Proarrhythmic effects of antiarrhythmic drugs. Am J Cardiol. 1987 Apr 30;59(11):26E–31E. doi: 10.1016/0002-9149(87)90198-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES